Covered recipient · General Payments record
MUHAMMAD A IMRAN
Allopathic & Osteopathic Physicians Internal Medicine Allergy & Immunology
General Payments · PY2018–2024
$2,448.51
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $370.68 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $207.50 | 6 |
| Amgen Inc. | $62.81 | 3 |
| GlaxoSmithKline, LLC. | $37.03 | 2 |
| Blueprint Medicines Corporation | $27.14 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.34 | 1 |
| Galderma Laboratories, L.P. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $28.83 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115750697 | CMS |
| Amgen Inc. | $16.81 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115750706 | CMS |
| Amgen Inc. | $17.17 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585663 | CMS |
| Blueprint Medicines Corporation | $27.14 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147452743 | CMS |
| Galderma Laboratories, L.P. | $13.86 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145305773 | CMS |
| GENZYME CORPORATION | $38.93 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594274 | CMS |
| GENZYME CORPORATION | $46.69 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594316 | CMS |
| GENZYME CORPORATION | $34.63 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594320 | CMS |
| GENZYME CORPORATION | $40.86 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594376 | CMS |
| GENZYME CORPORATION | $24.66 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594374 | CMS |
| GENZYME CORPORATION | $21.73 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594380 | CMS |
| GlaxoSmithKline, LLC. | $22.79 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116375508 | CMS |
| GlaxoSmithKline, LLC. | $14.24 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116722835 | CMS |
| Novartis Pharmaceuticals Corporation | $22.34 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086941939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.